National Bank of Austria
12
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.3%
1 terminated/withdrawn out of 12 trials
87.5%
+1.0% vs industry average
17%
2 trials in Phase 3/4
29%
2 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
The Effects of Intravenous Heme Arginate on Heme Oxygenase-1 Expression (HO-1) and Oxidative Stress in the Human Heart
Role: collaborator
Bright Light Therapy as Possible Treatment Option for MS-Fatigue
Role: collaborator
Cognitive Function in Elderly Marathon Runners
Role: collaborator
Randomised Controlled Study on the Use of Psychoeducation for Bulimia Nervosa in Young Women
Role: collaborator
Non-invasive Assessment of Pulmonary Artery Pressure
Role: collaborator
n-3 Polyunsaturated Fatty Acids in Obesity
Role: collaborator
Ecology of Medical Care - Utilisation of Health Care in Austria
Role: collaborator
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Role: collaborator
Use of Mobile Teledermatology in the Care of Acne Patients
Role: collaborator
The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis
Role: collaborator
Interventions to Prevent Adolescents With Type 1 Diabetes From Long-term Complications
Role: collaborator
Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus
Role: collaborator
All 12 trials loaded